Loading immersive experience

/hero-video.mp4

Reversing
Biological Time

Through proprietary autologous cell technology that restores youthful function

Evidence-Based Medicine

Clinical Results ThatSpeak for Themselves

90%

Autoimmune symptom relief

67%

Osteoarthritis improvement

37

Alzheimer's patients treated

20B

Cells from 1cm² tissue

Our autologous rejuvenated fibroblast (auto-rFib) technology represents a breakthrough in regenerative medicine, achieving measurable improvements across multiple conditions through the power of your own cells.

View the research behind these results

The Journey to Renewal

Your Rejuvenation Process

From collection to results in six precise steps, each designed to ensure the highest quality and safety standards for your cellular therapy.

Tissue Collection
1

Tissue Collection

A small 1cm² skin biopsy is collected from behind the ear under local anesthesia

Cell Isolation
2

Cell Isolation

Fibroblasts are isolated and expanded in our GMP-certified laboratories

Rejuvenation Protocol
3

Rejuvenation Protocol

Proprietary 15-day treatment reverses cellular aging markers to embryonic levels

Quality Validation
4

Quality Validation

Single-cell RNA sequencing confirms successful rejuvenation before release

Therapeutic Delivery
5

Therapeutic Delivery

20 billion rejuvenated cells delivered via targeted injection or IV infusion

Results & Monitoring
6

Results & Monitoring

Extended telomeres and rejuvenated cellular markers confirmed through comprehensive testing

Our complete rejuvenation process takes approximately 22 days from start to finish

The Science Behind
Our Success

Our breakthrough builds on Nobel Prize-winning research in cellular reprogramming, creating a new paradigm in regenerative medicine.

Epigenetic Reprogramming

Teaching old cells to remember their youthful state

100+ Peer-Reviewed Papers

Published in Cell, Nature, and Science journals

Multi-Pathway Approach

Immune modulation, growth factors, and tissue repair

9+ Patents Protected

Proprietary methods developed with UCLA

Our GMP Facility

World-Class Standards for Life-Changing Therapies

Our state-of-the-art GMP (Good Manufacturing Practice) certified facility represents the gold standard in cellular therapy production. Every step, from initial cell processing to final product release, adheres to the strictest international quality standards.

With advanced clean room technology, real-time monitoring systems, and rigorous quality control protocols, we transform a tiny skin sample into 20 billion therapeutic cells with industry-leading precision and care.

ISO 9001:2015 & GMP Certified

Meeting the highest international standards

Class 100/ISO 5 Clean Rooms

Ultra-sterile environments for cell processing

Real-Time Quality Monitoring

Continuous validation throughout production

GMP certified clean room facility with advanced bioreactors
Laboratory technician in sterile environment
Quality control testing equipment
Cell culture monitoring systems
Advanced laboratory equipment and monitoring

World-Class
Scientific Leadership

Our multidisciplinary team spans molecular biology, clinical medicine, finance, and biotechnology commercialization.

Diederik van der Reijt

Diederik van der Reijt

CEO & Chairman

Serial biotech entrepreneur and investor

Dr. Yi Eve Sun

Dr. Yi Eve Sun

Professor, UCLA

Former Deputy Director of UCLA Stem Cell Biology

Dr. Lin Quan

Dr. Lin Quan

Chief Scientist, IDDRC Center, UCLA

Clinical Director for preclinical research

Dr. Adeel Khan

Dr. Adeel Khan

Clinical Advisor, Regenerative Medicine

Board-certified physician and Co-founder of Minicircle

Dr. Joseph Regan

Dr. Joseph Regan

Non-Executive Director

Groundbreaking cancer stem cell pathway research

Jamie Grooms

Jamie Grooms

Executive Board Member

CEO of NKore Biotherapeutics

Stephen Bradley

Stephen Bradley

Non-Executive Director

Former British Consul-General to Hong Kong

Neil Bush

Neil Bush

Senior Advisor

40+ years as global business leader

Dave Bizer

Dave Bizer

Senior Investment Advisor

Co-founder of GCW Global Customised Wealth

Rachid Bouzouba

Rachid Bouzouba

Senior Capital Markets Advisor

Veteran financier with 30+ years' experience

Rogier van Bijnen

Rogier van Bijnen

Legal Advisor

Asia-Pacific life sciences legal practice

Shirin Azad

Shirin Azad

Co-Founder

Author and investor in biotech talent and funding

Paul Spiegel

Paul Spiegel

Strategic Advisor

International business development executive

Our research builds on foundational work in induced pluripotent stem cells, with 9+ proprietary patents protecting our breakthrough approaches.

Partner With Us to
Advance Human Longevity

Whether you're an investor, researcher, healthcare provider, or patient, join us in revolutionizing regenerative medicine.

Begin Your Journey to
Cellular Regeneration

Join pioneering institutions and individuals who are redefining the boundaries of human healthspan through autologous cell therapy.